News

Explore treatment resistance at the 2024 APA Annual Meeting!

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

An expert gives us a preview of the clinical pearls clinicians can expect from his presentations at this year’s APA Annual Meeting.

Which is the best recommendation for the treatment of alcohol use disorder?

What is new in research on major depressive disorder?

Don't miss these 2 APA Annual Meeting sessions on personality disorders!

We asked some of the presenters and attendees of the upcoming 2024 APA Annual Meeting what they were excited about. Here's what they said.

Frontal lobe syndrome can present with a range of behaviors that do not meet traditional dementia/neurocognitive disorder criteria.

The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.

How a radical proposal from California and 3 cases of anorexia nervosa from Colorado exemplify the "slippery slope" of physician-assisted suicide.

“The fundamental act of medical care is assumption of responsibility.”

Our Editorial Board members are delivering expert perspectives on a wide variety of psychiatric issues and disorders.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

What are the cultural psychiatry perspectives on personality disorders? Don't miss this APA session!

A late eulogy for George Tarjan, MD…

Wisdom, age, and the presidential election...

Challenging what is normal and the value of order.

Write to us now to be part of our series focused on mental health awareness this month.

The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.

The proposed change acknowledges the medical applications of marijuana.

The addition of 30 mg of evenamide to patients’ current antipsychotic medication was associated with a highly statistically significant reduction in the PANSS Total Score.

Check out this review of Ronald W. Pies’ latest book!

It’s time to center homelessness in the conversation around mental health.

A look at the distinction between qualifying conditions and FDA-approved indications for medical marijuana use.

Here are some updates from the world of psychiatry throughout the month of April.

A psychiatrist explores ketamine-assisted psychotherapy in this ongoing series.

Are you coming to the 2024 APA Annual Meeting? We'll see you there!

How do the current student protests compare with that of the late 60s?

The experts weighed in on a wide variety of psychiatric issues for the April issue of Psychiatric Times.